The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Meyer, J. H.
* Articles by Links, P.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Meyer, J. H.
* Articles by Links, P.
Related Collections
* Child/Adolescent Psychiatry
* Depression
* Suicide
Am J Psychiatry 160:90-99, January 2003
© 2003 American Psychiatric Association


Article

Dysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm

Jeffrey H. Meyer, M.D., Ph.D., Shelley McMain, Ph.D., Sidney H. Kennedy, M.D., Lorne Korman, Ph.D., Gregory M. Brown, M.D., Ph.D., Jean N. DaSilva, Ph.D., Alan A. Wilson, Ph.D., Thomas Blak, B.A., Rahel Eynan-Harvey, M.A., Verdell S. Goulding, B.Sc., Sylvain Houle, M.D., Ph.D., and Paul Links, M.D.

OBJECTIVE: Dysfunctional attitudes are negatively biased assumptions and beliefs regarding oneself, the world, and the future. In healthy subjects, increasing serotonin (5-HT) agonism with a single dose of d-fenfluramine lowered dysfunctional attitudes. To investigate whether the converse, a low level of 5-HT agonism, could account for the higher levels of dysfunctional attitudes observed in patients with major depression or with self-injurious behavior, cortex 5-HT2 receptor binding potential and dysfunctional attitudes were measured in patients with major depressive disorder, patients with a history of self-injurious behavior, and healthy comparison subjects (5-HT2 receptor density increases during 5-HT depletion). METHOD: Twenty-nine healthy subjects were recruited to evaluate the effect of d-fenfluramine or of clonidine (control condition) on dysfunctional attitudes. Dysfunctional attitudes were assessed with the Dysfunctional Attitude Scale 1 hour before and 1 hour after drug administration. In a second experiment, dysfunctional attitudes and 5-HT2 binding potential were measured in 22 patients with a major depressive episode secondary to major depressive disorder, 18 patients with a history of self-injurious behavior occurring outside of a depressive episode, and another 29 age-matched healthy subjects. Cortex 5-HT2 binding potential was measured with [18F]setoperone positron emission tomography. RESULTS: In the first experiment, dysfunctional attitudes decreased after administration of d-fenfluramine. In the second experiment, in the depressed group, dysfunctional attitudes were positively associated with cortex 5-HT2 binding potential, especially in Brodmann’s area 9 (after adjustment for age). Depressed subjects with extremely dysfunctional attitudes had higher 5-HT2 binding potential, compared to healthy subjects, particularly in Brodmann’s area 9. CONCLUSIONS: Low levels of 5-HT agonism in the brain cortex may explain the severely pessimistic, dysfunctional attitudes associated with major depression.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
A. T. Beck
The Evolution of the Cognitive Model of Depression and Its Neurobiological Correlates
Am J Psychiatry, August 1, 2008; 165(8): 969 - 977.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
D. A. Barton, M. D. Esler, T. Dawood, E. A. Lambert, D. Haikerwal, C. Brenchley, F. Socratous, J. Hastings, L. Guo, G. Wiesner, et al.
Elevated Brain Serotonin Turnover in Patients With Depression: Effect of Genotype and Therapy
Arch Gen Psychiatry, January 1, 2008; 65(1): 38 - 46.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. H. Meyer, N. Ginovart, A. Boovariwala, S. Sagrati, D. Hussey, A. Garcia, T. Young, N. Praschak-Rieder, A. A. Wilson, and S. Houle
Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression.
Arch Gen Psychiatry, November 1, 2006; 63(11): 1209 - 1216.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
Z. Bhagwagar, R. Hinz, M. Taylor, S. Fancy, P. Cowen, and P. Grasby
Increased 5-HT2A Receptor Binding in Euthymic, Medication-Free Patients Recovered From Depression: A Positron Emission Study With [11C]MDL 100,907
Am J Psychiatry, September 1, 2006; 163(9): 1580 - 1587.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. T. Beck
The Current State of Cognitive Therapy: A 40-Year Retrospective
Arch Gen Psychiatry, September 1, 2005; 62(9): 953 - 959.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. H. Meyer, S. Houle, S. Sagrati, A. Carella, D. F. Hussey, N. Ginovart, V. Goulding, J. Kennedy, and A. A. Wilson
Brain Serotonin Transporter Binding Potential Measured With Carbon 11-Labeled DASB Positron Emission Tomography: Effects of Major Depressive Episodes and Severity of Dysfunctional Attitudes
Arch Gen Psychiatry, December 1, 2004; 61(12): 1271 - 1279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. H. Meyer, A. A. Wilson, S. Sagrati, D. Hussey, A. Carella, W. Z. Potter, N. Ginovart, E. P. Spencer, A. Cheok, and S. Houle
Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study
Am J Psychiatry, May 1, 2004; 161(5): 826 - 835.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
C. VAN HEERINGEN and A. MARUSIC
Understanding the suicidal brain
The British Journal of Psychiatry, October 1, 2003; 183(4): 282 - 284.
[Full Text] [PDF]


Home page
Psychiatr. NewsHome page
J. Arehart-Treichel
Serotonin Paucity May Predict Pessimism in Depression
Psychiatr News, January 17, 2003; 38(2): 34 - 45.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org